MICS CABG

whitePaper | December 27, 2022

Year after year, the Life Sciences industry expands at a breakneck pace, with pharmaceutical development leading the way. Regulatory agencies prioritize patient safety in this highly regulated industry.

whitePaper | January 14, 2022

Advanced Therapy Medicinal Products (ATMPs) are at the forefront of global scientific innovation in healthcare. These pioneering treatments, which include gene therapies, somatic cell therapies and tissue engineered products, have the potential to transform patients’ lives

whitePaper | September 7, 2021

Numerous acquisitions and technology upgrades put many applications and associated data stores into a legacy state for a large, multi-state integrated healthcare provider network. The organization turned to Flatirons Digital Innovations (FDI) to help decommission those applications deemed most critical to save costs and eliminate risks associated with running aging legacy systems, while ensuring ongoing access to complete patient data.

whitePaper | May 16, 2023

The healthcare and life sciences communities have been undergoing a massive digital transformation since the COVID-19 pandemic. Everything from healthcare consumer expectations to government regulations are driving providers, payers, and pharmaceutical organizations to move aggressively toward digital interactions and transactions

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

whitePaper | December 6, 2022

Cybersecurity has become one of the most complex and urgent issues facing the healthcare industry. The number of cyber attacks continues to grow, and attackers are getting even more sophisticated at compromising systems.